AXPH Stock Overview
Alexandria Co. For Pharmaceuticals & Chemical Industries manufactures, markets, and distributes generic forms of human and animal health products in Egypt.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Alexandria Co. For Pharmaceuticals & Chemical Industries Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م226.00 |
| 52 Week High | ج.م249.98 |
| 52 Week Low | ج.م120.00 |
| Beta | 0.020 |
| 1 Month Change | -2.63% |
| 3 Month Change | 16.39% |
| 1 Year Change | 67.41% |
| 3 Year Change | 68.63% |
| 5 Year Change | 75.26% |
| Change since IPO | 593.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| AXPH | EG Pharmaceuticals | EG Market | |
|---|---|---|---|
| 7D | 0% | 0.9% | 3.5% |
| 1Y | 67.4% | 30.7% | 69.0% |
Return vs Industry: AXPH exceeded the EG Pharmaceuticals industry which returned 30.7% over the past year.
Return vs Market: AXPH underperformed the EG Market which returned 69% over the past year.
Price Volatility
| AXPH volatility | |
|---|---|
| AXPH Average Weekly Movement | 4.3% |
| Pharmaceuticals Industry Average Movement | 5.8% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in EG Market | 13.1% |
| 10% least volatile stocks in EG Market | 5.0% |
Stable Share Price: AXPH has not had significant price volatility in the past 3 months.
Volatility Over Time: AXPH's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Mahmoud Rizk | www.alexcopharma.net |
Alexandria Co. For Pharmaceuticals & Chemical Industries manufactures, markets, and distributes generic forms of human and animal health products in Egypt. It also offers medical appliances. The company is based in Alexandria, Egypt.
Alexandria Co. For Pharmaceuticals & Chemical Industries Fundamentals Summary
| AXPH fundamental statistics | |
|---|---|
| Market cap | ج.م1.13b |
| Earnings (TTM) | ج.م151.02m |
| Revenue (TTM) | ج.م1.63b |
7.5x
P/E Ratio0.7x
P/S RatioIs AXPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AXPH income statement (TTM) | |
|---|---|
| Revenue | ج.م1.63b |
| Cost of Revenue | ج.م1.34b |
| Gross Profit | ج.م292.66m |
| Other Expenses | ج.م141.64m |
| Earnings | ج.م151.02m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 30.20 |
| Gross Margin | 17.98% |
| Net Profit Margin | 9.28% |
| Debt/Equity Ratio | 0.9% |
How did AXPH perform over the long term?
See historical performance and comparison